{"id":117599,"name":"COLLEGE OF PSYCHIATRIC AND NEUROLOGIC PHARMACISTS","slug":"college-of-psychiatric-and-neurologic-pharmacists","state":"NE","country":"United States of America","description":"Increase access to treatment for mental illness, substance abuse and neurological disorder","totalSpending":320000,"filings":17,"yearlySpending":[{"year":2018,"income":80000},{"year":2019,"income":80000},{"year":2020,"income":80000},{"year":2021,"income":80000},{"year":2022,"income":0}],"issues":["MMM","HCR","BUD"],"firms":["FAEGRE DRINKER BIDDLE & REATH LLP"],"lobbyists":["JEREMY SCOTT","SARAH MILLS","LAURA HANEN","ERIN PRENDERGAST"],"govEntities":["HOUSE OF REPRESENTATIVES","SENATE","Health & Human Services, Dept of (HHS)","Centers For Medicare and Medicaid Services (CMS)","Office of Management & Budget (OMB)"],"sampleDescriptions":["HR 592/ S. 109, Pharmacy and Medically Underserved Areas Enhancement Act.","Mental health issues; Opioid Issues; House Ways and Means Committee letter on opioid crisis; finance committee letter on opioid crisis; HR 4778/ S. 2301, the Behavior Health Coverage Transparency Act;","FY 2018 Appropriations (Consolidated Appropriation Act) related to health professions (HRSA Title VII) and opioids; FY 19 appropriation (LHHS) related to health professions (HRSA Title VII) and opioid","Mental health issues; Opioid Issues; Draft opioid legislation; Including Families in Mental Health Recovery Act; S. 2524 Substance Use Disorder Workforce Loan Repayment Act of 2018; S. 2680 Opioid Cri","HR 592/ S. 109, Pharmacy and Medically Under-served Areas Enhancement Act; Letter to Sec. Azar regarding Part D's six protected classes."],"years":[2018,2019,2020,2021,2022]}